Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant Cyclophosphamide

被引：2
|
作者：
Eastburg, Luke [1 ]
Russler-Germain, David A. [2 ]
Abboud, Ramzi [2 ]
Westervelt, Peter [3 ]
DiPersio, John F. [4 ]
Becker, Michael W. [1 ]
Kumar, Neha [1 ]
Aljitawi, Omar S. [1 ]
Andolina, Jeffrey R. [1 ]
Fountaine, Thomas J. [1 ,5 ]
Liesveld, Jane L. [6 ]
Huselton, Eric [7 ]
机构：
[1] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[2] Washington Univ, Sch Med, St Louis, MO USA
[3] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
[4] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[5] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY USA
[6] Univ Rochester, Wilmot Canc Inst, Rochester, NY USA
[7] Univ Rochester, Div Hematol & Oncol, Med Ctr, Rochester, NY USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-129872
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4496
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Increased early mortality after fludarabine and melphalan conditioning with peripheral blood grafts in haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide
    Eastburg, Luke
    Russler-Germain, David A.
    DiPersio, John F.
    Fountaine, Thomas
    Andolina, Jeffrey R.
    Abboud, Ramzi
    Huselton, Eric
    [J]. LEUKEMIA & LYMPHOMA, 2022, 63 (01) : 222 - 226
  • [2] Invasive fungal infection after peripheral blood non-manipulated haploidentical SCT with post-transplant cyclophosphamide
    Oarbeascoa, Gillen
    Dorado, Nieves
    Solan, Laura
    Bailen, Rebeca
    Balsalobre, Pascual
    Martinez-Laperche, Carolina
    Buno, Ismael
    Anguita, Javier
    Luis Diez-Martin, Jose
    Kwon, Mi
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 410 - 410
  • [3] Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide with Busulfan, Fludarabine and Thiotepa Conditioning for Children with Thalassemia Major
    Yadav, Satya Prakash
    Sharma, Anil
    Kapoor, Rohit
    Chatterjee, Goutomi
    Rastogi, Neha
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S218 - S219
  • [4] Impact of The Addition of Antithymocyte Globulin to Post-Transplant Cyclophosphamide in Haploidentical Transplantation With Peripheral Blood Compared to Post-Transplant Cyclophosphamide Alone
    Battipaglia, Giorgia
    Labopin, Myriam
    Blaise, Didier
    Diez-Martin, Jose Luis
    Bazarbachi, Ali
    Vitek, Antonin
    Chevallier, Patrice
    Castagna, Luca
    Grillo, Giovanni
    Deconinck, Eric
    Lopez-Jimenez, Javier
    Koc, Yener
    Ruggeri, Annalisa
    Nagler, Arnon
    Mohty, Mohamad
    [J]. BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 56 - 57
  • [5] Poor graft function after unmanipulated haploidentical SCT with post-transplant high dose cyclophosphamide
    Gomez-Centurion, Ignacio
    Balsalobre, Pascual
    Perez Corral, Ana
    Dorado, Nieves
    Solan, Laura
    Bailen, Rebeca
    Monsalvo, Silvia
    Martinez Laperche, Carolina
    Buno, Ismael
    Anguita, Javier
    Luis Diez-Martin, Jose
    Kwon, Mi
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 243 - 244
  • [6] Outcomes of Patients Undergoing Fludarabine and Melphalan-Based Conditioning with Post-Transplant Cyclophosphamide for Peripheral Blood Stem Cell Allogeneic Hematopoietic Cell Transplant: Donor Type Effect
    Othman, Tamer
    Koller, Paul B.
    Yang, Dongyun
    Mokhtari, Sally
    Blackmon, Amanda
    Agrawal, Vaibhav
    Pourhassan, Hoda
    Ball, Brian J.
    Amanam, Idoroenyi
    Arslan, Shukaib
    Otoukesh, Salman
    Sandhu, Karamjeet S.
    Aldoss, Ibrahim
    Ali, Haris
    Salhotra, Amandeep
    Aribi, Ahmed
    Artz, Andrew
    Samara, Yazeed
    Becker, Pamela S.
    Pullarkat, Vinod
    Stewart, Forest Marc
    Smith, Eileen Patricia
    Stein, Anthony
    Marcucci, Guido
    Forman, Stephen J.
    Nakamura, Ryotaro
    Al Malki, Monzr M.
    [J]. BLOOD, 2023, 142
  • [7] BONE MARROW COMPARED TO PERIPHERAL BLOOD STEM CELL FOR HAPLOIDENTICAL TRANSPLANTATION WITH NONMYELOBLATIVE CONDITIONING REGIMEN AND POST-TRANSPLANT CYCLOPHOSPHAMIDE
    Castagna, L.
    Crocchiolo, R.
    Furst, S.
    Bramanti, S.
    El Cheikh, J.
    Sarina, B.
    Granata, A.
    Mauro, E.
    Faucher, C.
    Mohty, B.
    Harbi, S.
    Chabannon, C.
    Carlo-Stella, C.
    Santoro, A.
    Blaise, D.
    [J]. BONE MARROW TRANSPLANTATION, 2014, 49 : S518 - S518
  • [8] Immune Reconstitution and Outcomes after Peripheral Blood Haploidentical Transplantation with Novel Conditioning and Post-Transplant Cyclophosphomide (PTCY)
    Khaled, Yasser
    Owolabi, Diwura
    Parks, Christy R.
    Lamontagne, Deborah
    Boss, Joshua D.
    Chandler, Jason
    Huseynov, Valeh
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S165 - S166
  • [9] More about post-transplant cyclophosphamide in haploidentical grafts: full or reduced doses?
    Manuel Gallardo-Perez, Moises
    Homero Gutierrez-Aguirre, Cesar
    Carlos Olivares-Gazca, Juan
    Jose Ruiz-Arguelles, Guillermo
    [J]. HEMATOLOGY, 2024, 29 (01)
  • [10] Reduced Dose of Post-Transplant Cyclophosphamide for HLA Haploidentical Peripheral Blood Stem Cell Transplantation
    Morishige, Satoshi
    Yamasaki, Yoshitaka
    Oya, Shuki
    Nakamura, Takayuki
    Ymaguchi, Maki
    Aoyama, Kazutoshi
    Seki, Ritsuko
    Mouri, Fumihiko
    Osaki, Koichi
    Nagafuji, Koji
    [J]. BLOOD, 2018, 132
12345